A new apparatus called Bypass Trapped Flow Analysis System (ByT-FAS) is described. A properly designed ByT-FAS gives an analyst the ability to use analyte sample volumes of 10 to 200 μL [or more] and reagent volumes of approximately the same size. The sample and reagent are injected into their respective carrier streams and attain physical steady state concentrations in the detection cell within approximately 15 to 45 seconds after injection. Upon achievement of simultaneous sample and reagent physical steady state concentrations, the system flow is diverted around the detection cell and the reaction mixture is trapped in the detection cell. The concentration of the sample and reagent in the detection cell can be readily computed from knowledge of the original concentrations of the sample and reagent and the flow rates of the streams propelling the sample and reagent. ByT-FAS was demonstrated to be useful for direct measurements of analytes in liquid solutions and for assays which utilize equilibrium and/or kinetic methods to create measurable product(s) for ultraviolet/visible spectrophotometry, fluorimetry, and chemiluminescence. Enzyme activities and fundamental enzyme kinetic parameters (Kms, Kis, VMAXs) were determined directly. Genetic transcription levels of luciferase in whole intact E. coli cells were also determined using chemiluminescent detection. Flow system configuration, components, and flow ratios were investigated for their effects on achieving physical steady state signals in the detector. It is believed that this new type of instrumentation will be of significant use for the analytical chemical, biochemical, molecular biology, biotechnology, environmental, pharmaceutical and medical communities for those measurements which require direct knowledge of the concentration of the reactants and products during quantitation. / Ph. D.

Many different chemicals are used in the everyday life, like detergents and pharmaceuticals. However, their production has a big impact on health and environment as much of the raw materials are not renewable and the standard ways of production in many cases includes toxic and environmentally hazardous components. As the population and as the life standard increases all over the planet, the demand for different important chemicals, like pharmaceuticals, will increase. A way to handle this is to apply the concept of Green chemistry, where biocatalysis, in the form of enzymes, is a very good alternative. Enzymes do not normally function in industrial processes and needs modifications through protein engineering to cope in such conditions. To be able to efficiently improve an enzyme, there is a need to understand the mechanism and characteristics of that enzyme. Acyloins (α-hydroxy ketones) are important building blocks in the synthesis of pharmaceuticals. In this thesis, the enzyme alcohol dehydrogenase A (ADH-A) from Rhodococcus ruber has been in focus, as it has been shown to display a wide substrate scope, also accepting aryl-substituted alcohols. The aim has been to study the usefulness of ADH-A as a biocatalyst towards production of acyloins and its activity with aryl-substituted vicinal diols and to study substrate-, regio-, and enantioselectivity of this enzyme. This thesis is based on four different papers where the focus of the first has been to biochemically characterize ADH-A and determine its mechanism, kinetics and its substrate-, regio-, and enantioselectivity. The second and third paper aims towards deeper understanding of some aspects of selectivity of ADH-A. Non-productive binding and its importance for enantioselectivity is studied in the second paper by evolving ADH-A towards increased activity with the least favored enantiomer through protein engineering. In the third paper, regioselectivity is in focus, where an evolved variant displaying reversed regioselectivity is studied. In the fourth and last paper ADH-A is studied towards the possibility to increase its activity towards aryl-substituted vicinal diols, with R-1-phenyl ethane-1,2-diol as the model substrate, and the possibility to link ADH-A with an epoxide hydrolase to produce acyloins from racemic epoxides.

Genetic mutations can cause a wide range of diseases, e.g. cancer. Gene therapy has the potential to alleviate or even cure these diseases. One of the many gene therapies developed so far is RNA-cleaving deoxyribozymes, short DNA oligonucleotides that specifically bind to and cleave RNA. Since the development of these synthetic catalytic oligonucleotides, the main way of determining their cleavage kinetics has been through the use of a laborious and error prone gel assay to quantify substrate and product at different time-points. We have developed two new methods for this purpose. The first one includes a fluorescent intercalating dye, PicoGreen, which has an increased fluorescence upon binding double-stranded oligonucleotides; during the course of the reaction the fluorescence intensity will decrease as the RNA is cleaved and dissociates from the deoxyribozyme. A second method was developed based on the common denominator of all nucleases, each cleavage event exposes a single phosphate of the oligonucleotide phosphate backbone; the exposed phosphate can simultaneously be released by a phosphatase and directly quantified by a fluorescent phosphate sensor. This method allows for multiple turnover kinetics of diverse types of nucleases, including deoxyribozymes and protein nucleases. The main challenge of gene therapy is often the delivery into the cell. To bypass cellular defenses researchers have used a vast number of methods; one of these are cell-penetrating peptides which can be either covalently coupled to or non-covalently complexed with a cargo to deliver it into a cell. To further evolve cell-penetrating peptides and understand how they work we developed an assay to be able to quickly screen different conditions in a high-throughput manner. A luciferase up- and downregulation experiment was used together with a reduction of the experimental time by 1 day, upscaling from 24- to 96-well plates and the cost was reduced by 95% compared to commercially available assays. In the last paper we evaluated if cell-penetrating peptides could be used to improve the uptake of an LNA oligonucleotide mimic of GRN163L, a telomerase-inhibiting oligonucleotide. The combination of cell-penetrating peptides and our mimic oligonucleotide lead to an IC50 more than 20 times lower than that of GRN163L.

A newly discovered cysteine protease, Prp, has been shown to perform an essential, site-specific cleavage of ribosomal protein L27 in Staphylococcus aureus. In Firmicutes and related bacteria, ribosomal protein L27 is encoded with a conserved N-terminal extension that must be removed to expose residues critical for ribosome function. Uncleavable and pre-cleaved variants were unable to complement an L27 deletion in S. aureus, indicating that this N-terminal processing event is essential and likely plays an important regulatory role. The gene encoding the responsible protease (prp) has been shown to be essential, and is found in all organisms encoding the N-terminal extension of L27. Cleavage of L27 by Prp represents a new target for potential antibiotic therapy. In order to characterize this protease, Prp has been overexpressed and purified. Using an assay we have developed, based on cleavage of a fluorogenic peptide derived from the conserved L27 cleavage sequence, we have undertaken an analysis of the enzyme kinetics and substrate specificity for Prp cleavage and tested predictions made based on a structural model using active-site mutants.

This dissertation thesis focuses on creating tools for the analysis and potential therapeutic intervention in the biological processes regulated by proteolysis. I focus on two important proteolytic enzymes: HIV-1 protease, which is indispensable for the polyprotein processing of the nascent virus and thus for the development of infectious viral particle, and glutamate carboxypeptidase II, a tumor marker and a neuropeptidase from the prostate and central nervous system. Rational design of inhibitors of these therapeutically relevant enzymes serves two purposes: firstly, protease inhibitors were shown to be powerful drugs (HIV protease is in fact the example of successful drug development driven by structural biology). Secondly, and in the context of this thesis perhaps more importantly, inhibitors of medicinally relevant proteases might serve as tools for the elucidation of basic biological questions concerning regulation, timing and spatiotemporal control of such key processes as virus maturation or cancer development. The experimental work described in this thesis summarizes my results in both these areas. Human Immunodeficiency Virus Protease Human immunodeficiency virus (HIV), a causative agent of AIDS, has been estimated to kill close to 40 million people during the past four decades with 1.5...

O uso intensivo de produtos organoclorados contendo estruturas aromáticas em sua composição tem crescido de forma rápida nos últimos anos em face de sua ampla utilização em vários setores da indústria moderna. A decomposição de tais compostos é lenta, dada sua grande estabilidade química, tornando-os poluentes recorrentes do meio-ambiente. Diferentes estratégias estão disponíveis para tentar solucionar este problema. Os chamados processos de bioremediação estão entre elas e vem ganhando espaço dentre as possíveis escolhas em face de sua maior eficiência e por estarem baseados no uso de moléculas como enzimas, que não afetam o ambiente, para realizar a tarefa de degradação de substâncias tóxicas. Neste contexto se coloca a enzima clorocatecol 1,2-dioxigenase de Pseudomonas. putida, alvo de estudos deste trabalho. Nosso grupo tem trabalhado no entendimento do mecanismo de ação da enzima clorocatecol 1,2-dioxigenase de Pseudomonas. putida há alguns anos já que acreditamos que a utilização de forma mais eficiente e efetiva possível da enzima clorocatecol 1,2-dioxigenase de Pseudomonas. putida passa necessariamente pelo conhecimento acerca de maneiras de controle da atividade enzimática. Com isso, os resultados obtidos consistiram na otimização dos processos de expressão e purificação que permitiram a obtenção da proteína pura e com bom rendimento, após mudança no vetor de expressão. Foram feitos ensaios de atividade enzimática com diferentes substratos e desenvolvimento de um protocolo de caracterização cinética, para assim avaliar a existência de mecanismos de inibição/modulação da reação pelo substrato e/ou produto. Análise da estrutura secundária por meio de dicroísmo circular e dicroísmo circular com radiação síncrotron para avaliar a integridade estrutural frente da nova construção. Também foram realizados testes para separação dos ligantes enzima clorocatecol 1,2-dioxigenase de Pseudomonas putida para análise em espectrômetro de massas afim de se identificar as moléculas anfipáticas que podem estar presentes em seu sítio hidrofóbico. Por fim, ensaios de interação proteína-lipídio utilizando calorimetria diferencial de varredura, ressonância paramagnética eletrônica e dicroísmo circular indicam uma provável interação com modelos de membrana, principalmente, quando na presença de PIP2 (fosfatidilinositol-4,5-bisfosfato). / The use of chlorinated compounds bearing aromatic structures in their chemical composition has quickly grown in the last few years due to their general presence in processes of modern industry. The degradation of such compounds is slow, due to their high chemical stability, thus making them frequent polutants of the environment. Different strategies to tackle this problem are available. The so-called bioremediation methods are among those strategies and have been gaining many applications because of their higher efficiency and due to the use of enzymes, which do not affect the environment, to perform the degradation task. Chlorocatechol 1,2-dioxygenase from Pseudomonas putida is one of those enzymes and is the object of study of this project. Our group has been working on understanding the mechanism of action of Chlorocatechol 1,2-dioxygenase from Pseudomonas putida since we believe that a more efficient use of Chlorocatechol 1,2-dioxygenase from Pseudomonas putida necessarily involves knowledge about ways of controlling the enzymatic activity. Thus, our results consisted in the optimization of the expression and purification protocols that allow the production of pure protein in high yields after changing its expression vector. Assays of enzyme activity with different substrates and development of a protocol for kinetic characterization was also done to assess the existence of mechanisms of inhibition/modulation of the reaction by the substrate and/or product. Analysis of the secondary structure by circular dichroism and synchrotron radiation circular dichroism was also performed to assess the integrity of the new construction. Tests were also carried out to separate the amphipatic ligands present in the Chlorocatechol 1,2-dioxygenase from Pseudomonas putida structure for analysis in a mass spectrometer in order to identify which kind of amphipathic molecule may be present in enzyme hydrophobic site. Finally, lipid-protein interactions were investigated by means of differential scanning calorimetry, electron paramagnetic resonance and circular dichroism. The results indicated a potential interaction with model membranes, especially in the presence of PIP2 (phosphatidylinositol 4,5-bisphosphate).

The cytochrome P450 enzyme system is a multicomponent electron-transfer chain composed of a haem-containing monooxygenase cytochrome P450 (CYP) and one or more redox partners. Eukaryotic CYPs and their redox partner NADPH-dependent cytochrome P450 oxidoreductase (CPR) are involved in many biological processes. Each protein has one N- terminal membrane anchor domain for location within the endoplasmic reticulum (ER). In mammals, CYPs and CPR are especially abundant in liver cells, where they play important roles in the metabolism of steroids, fatty acids, and xenobiotic compounds including numerous drugs of pharmaceutical importance. Incorporation into lipid membranes is an important aspect of CYP and CPR function, influencing their kinetic properties and interactions. In this thesis, soluble nanometer-scale phospholipid bilayer membrane discs, "nanodiscs", were used as a reconstitution system to study the influence of lipid membrane composition on the activities of the abundant human CYP3A4 and human CPR. Both enzymes were expressed and purified from bacteria, and assembled into functionally active membrane-bound complexes in nanodiscs. Nanodisc assembly was assessed by a combination of native and denaturing gel electrophoresis, and a fluorimetric assay was developed to study CYP3A4 reaction kinetics using 7-benzyloxyquinoline as substrate. Kinetic properties were investigated with respect to different lipid membrane compositions: phosphatidyl choline; a synthetic lipid mixture resembling the ER; and natural lipids extracted from liver microsomes. Full activity of the CYP3A4 system, with electron transfer from NADPH via CPR, could only be reconstituted when both CYP3A4 and CPR were membrane-bound within the same nanodiscs. No activity was observed when CPR and CYP3A4 were each incorporated seperately into naodiscs then mixed together, or when soluble forms of CPR were mixed with pre-assembled CYP3A4-nanodiscs. Thus, assembly of the two proteins within the same membrane was shown to be essential for the function of the CPR-CYP3A4 electron transfer system. Comparison of the reaction kinetics in different membrane compositions revealed liver microsomal lipid to have an enhancing effect both on the activity of the assembled CPR-CYP3A4 nanodisc complex, and on the activity of CPR alone incorporated in nanodiscs, when compared either to the synthetic lipid mixture or to phosphatidyl choline alone. Thus, natural lipids appear to possess properties or include components important for the catalytic function of the CYP system, which are absent from synthetic lipid. Input of electrons, measured by NADPH consumption, exceeded product formation rate by the CPR-CYP3A4 complex in nanodiscs, indicating "leakage" in the electron flow, possibly due to uncoupling of the two enzymes. Uncoupling was shown to occur by developing a novel fluorimetric method using the dye MitSOX to detect superoxide production. The significance of this, and to what extent control of coupling could be a natural means of regulation of the CPR-CYP system, remains to be determined. Thus, phospholipid bilayer nanodiscs prove a powerful tool to enable detailed analysis of the reaction kinetics of membrane-reconstituted CPR-CYP systems, and to allow pertinent questions to be addressed concerning the integral significance of the membrane environment.

O uso intensivo de produtos organoclorados contendo estruturas aromáticas em sua composição tem crescido de forma rápida nos últimos anos em face de sua ampla utilização em vários setores da indústria moderna. A decomposição de tais compostos é lenta, dada sua grande estabilidade química, tornando-os poluentes recorrentes do meio-ambiente. Diferentes estratégias estão disponíveis para tentar solucionar este problema. Os chamados processos de bioremediação estão entre elas e vem ganhando espaço dentre as possíveis escolhas em face de sua maior eficiência e por estarem baseados no uso de moléculas como enzimas, que não afetam o ambiente, para realizar a tarefa de degradação de substâncias tóxicas. Neste contexto se coloca a enzima clorocatecol 1,2-dioxigenase de Pseudomonas. putida, alvo de estudos deste trabalho. Nosso grupo tem trabalhado no entendimento do mecanismo de ação da enzima clorocatecol 1,2-dioxigenase de Pseudomonas. putida há alguns anos já que acreditamos que a utilização de forma mais eficiente e efetiva possível da enzima clorocatecol 1,2-dioxigenase de Pseudomonas. putida passa necessariamente pelo conhecimento acerca de maneiras de controle da atividade enzimática. Com isso, os resultados obtidos consistiram na otimização dos processos de expressão e purificação que permitiram a obtenção da proteína pura e com bom rendimento, após mudança no vetor de expressão. Foram feitos ensaios de atividade enzimática com diferentes substratos e desenvolvimento de um protocolo de caracterização cinética, para assim avaliar a existência de mecanismos de inibição/modulação da reação pelo substrato e/ou produto. Análise da estrutura secundária por meio de dicroísmo circular e dicroísmo circular com radiação síncrotron para avaliar a integridade estrutural frente da nova construção. Também foram realizados testes para separação dos ligantes enzima clorocatecol 1,2-dioxigenase de Pseudomonas putida para análise em espectrômetro de massas afim de se identificar as moléculas anfipáticas que podem estar presentes em seu sítio hidrofóbico. Por fim, ensaios de interação proteína-lipídio utilizando calorimetria diferencial de varredura, ressonância paramagnética eletrônica e dicroísmo circular indicam uma provável interação com modelos de membrana, principalmente, quando na presença de PIP2 (fosfatidilinositol-4,5-bisfosfato). / The use of chlorinated compounds bearing aromatic structures in their chemical composition has quickly grown in the last few years due to their general presence in processes of modern industry. The degradation of such compounds is slow, due to their high chemical stability, thus making them frequent polutants of the environment. Different strategies to tackle this problem are available. The so-called bioremediation methods are among those strategies and have been gaining many applications because of their higher efficiency and due to the use of enzymes, which do not affect the environment, to perform the degradation task. Chlorocatechol 1,2-dioxygenase from Pseudomonas putida is one of those enzymes and is the object of study of this project. Our group has been working on understanding the mechanism of action of Chlorocatechol 1,2-dioxygenase from Pseudomonas putida since we believe that a more efficient use of Chlorocatechol 1,2-dioxygenase from Pseudomonas putida necessarily involves knowledge about ways of controlling the enzymatic activity. Thus, our results consisted in the optimization of the expression and purification protocols that allow the production of pure protein in high yields after changing its expression vector. Assays of enzyme activity with different substrates and development of a protocol for kinetic characterization was also done to assess the existence of mechanisms of inhibition/modulation of the reaction by the substrate and/or product. Analysis of the secondary structure by circular dichroism and synchrotron radiation circular dichroism was also performed to assess the integrity of the new construction. Tests were also carried out to separate the amphipatic ligands present in the Chlorocatechol 1,2-dioxygenase from Pseudomonas putida structure for analysis in a mass spectrometer in order to identify which kind of amphipathic molecule may be present in enzyme hydrophobic site. Finally, lipid-protein interactions were investigated by means of differential scanning calorimetry, electron paramagnetic resonance and circular dichroism. The results indicated a potential interaction with model membranes, especially in the presence of PIP2 (phosphatidylinositol 4,5-bisphosphate).

Les isoprénoïdes, présents dans tous les organismes vivants, sont synthétisés selon deux processus: la voie du Mevalonate et la voie Méthylérythritol phosphate (MEP). Cette dernière, absente chez l’humain, est très étudiée car elle représente une cible pour le développement de nouveaux antimicrobiens. Le ME-N3, un analogue du méthylérythritol portant un azoture, a été synthétisé et exploité dans des expériences de marquage métabolique de la voie MEP en utilisant un couplage bioorthogonale suivi d’une analyse par LC/MS. De façon intéressante, nous avons découvert que le MEP-N3, un analogue du MEP, inhibe l'enzyme IspD d’ E. coli (3ème enzyme de la voie MEP). Les études cinétiques ont révélé que le MEP-N3 possède la meilleure activité inhibitrice sur IspD d’ E.coli en comparaison avec les inhibiteurs connus, et que le mécanisme d'inhibition est de type mixte. Une étude détaillée du mécanisme de la réaction catalysée par IspD a été réalisée pour la première fois, en utilisant une analyse cinétique à deux substrats. / Isoprenoids, present in all living organisms, are synthesised according to two routes: the Mevalonate and the Methylerythritol phosphate (MEP) pathways. The MEP pathway, absent in humans, is extensively investigated as it is a target for the development of new antimicrobials. ME-N3 an azide tagged analogue of methylerythritol was synthesised and utilised for metabolic labelling studies of the MEP pathway using bioorthogonal ligation followed by LC-MS analysis. Interestingly, we found that MEP-N3, an analogue of MEP, inhibits E.coli IspD (3rd enzyme of the MEP pathway). Further inhibition kinetic studies revealed that MEP-N3 possesses the highest inhibitory activity on E.coli ispD when compared to known inhibitors. In addition, the mechanism of inhibition of E.coli ispD by MEP-N3 was found to be best described using a mixed type model. Moreover, determination of the IspD reaction mechanism has been carried out for the first time, by virtue of a bisubstrate steady state kinetic analysis.

Blood coagulation is a series of biochemical reactions that take place to form a blood clot. Abnormalities in coagulation, such as under-clotting or over- clotting, can lead to significant blood loss, cardiac arrest, damage to vital organs, or even death. Thus, understanding quantitatively how blood coagulation works is important in informing clinical decisions about treating deficiencies and disorders. Quantifying blood coagulation is possible through mathematical modeling. This review presents different mathematical models that have been developed in the past 30 years to describe the biochemistry, biophysics, and clinical applications of blood coagulation research. This review includes the strengths and limitations of models, as well as suggestions for future work.